Morgan Stanley Upgrades Bioage Labs to Equal-Weight, Raises Price Target to $12
Benzinga Newsdesk 11 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Morgan Stanley analyst Jeffrey Hung upgrades Bioage Labs (NASDAQ:BIOA) from Underweight to Equal-Weight and raises the price target from $5 to $12.
Morgan Stanley analyst Jeffrey Hung upgrades Bioage Labs (NASDAQ:BIOA) from Underweight to Equal-Weight and raises the price target from $5 to $12.